INCIDENCE AND POTENTIAL MECHANISM(S) OF POST-PROCEDURAL RISE OF CARDIAC BIOMARKERS IN THE RANDOMIZED ABSORB II TRIAL COMPARING AN ABSORB SCAFFOLD AND A XIENCE STENT.

Yuki Katagiri, Patrick W. Serruys, Carlos Macaya, John A. Ormiston, Jonathan Hill, Iréne Lang, Mohaned Egred, Jean Fajadet, Maciej Lesiak, Joanna J. Wykrzykowska, Jan J. Piek, Manel Sabaté, Stephan Windecker, Bernard Chevalier, Yoshinobu Onuma

КАРДИОЛОГИЯ УЗБЕКИСТАНА

Article2019

TCTAP A-063 Endothelial Shear Stress and Vascular Remodeling in Bioresorbable Scaffold and Metallic Stent in the ABSORB II Trial

Erhan Tenekecioğlu, Yuki Katagiri, Ryo Torii, Christos V. Bourantas, Frank Gijsen, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2015

TCT-343 Post-procedural geometrical parameters and their impact on adverse cardiovascular events: insights from the ABSORB II trial

Pannipa Suwannasom, Felipe N. Albuquerque, Yuki Ishibashi, Yohei Sotomi, Carlos M. Campos, Yoon‐Kyoung Cho, Dariusz Dudek, Ángel Cequier, Didier Carrié, Andrés Íñiguez, Marcello Dominici, René J. van der Schaaf, Michael Haude, Bernard Chevalier, Hector M. Garcia Garcia, Robbert J. de Winter, Joanna J. Wykrzykowska, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Article2015

ACUTE RECOIL FOLLOWING IMPLANTATION OF EVEROLIMUS-ELUTING ABSORB BIODEGRADABLE VASCULAR SCAFFOLDS OR XIENCE METALLIC STENTS: THE ABSORB II TRIAL

Bernard Chevalier, Yuki Ishibashi, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

INCIDENCE AND POTENTIAL MECHANISM(S) OF POST-PROCEDURAL RISE OF CARDIAC BIOMARKERS IN THE RANDOMIZED ABSORB II TRIAL COMPARING AN ABSORB SCAFFOLD AND A XIENCE STENT.

Abstract

Discussion(0)

Related publications

DIFFERENCES IN THE OCCURRENCE OF NEW OR WORSENING ANGINA BETWEEN THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD AND XIENCE METALLIC STENT: A POST-HOC ANALYSIS OF THE ABSORB II RANDOMIZED TRIAL

The Long-Term Impact of Post-Procedural Asymmetry and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial

TCTAP A-063 Endothelial Shear Stress and Vascular Remodeling in Bioresorbable Scaffold and Metallic Stent in the ABSORB II Trial

TCT-343 Post-procedural geometrical parameters and their impact on adverse cardiovascular events: insights from the ABSORB II trial

ACUTE RECOIL FOLLOWING IMPLANTATION OF EVEROLIMUS-ELUTING ABSORB BIODEGRADABLE VASCULAR SCAFFOLDS OR XIENCE METALLIC STENTS: THE ABSORB II TRIAL